Default image

Jake Page

Investor of 4 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.

Why Evelo (EVLO): is up 26.92%

Why Evelo (EVLO): is up 26.92%
Evelo (EVLO) announced on December 9th that the company is developing a new modality of orally delivered medicines which act in the small intestine with systemic effects, today announced that it is prioritizing EDP1908 as its lead clinical candidate in…